Pakistan’s Pharma Sector Earns Global Recognition as Innovation and Export Reach New Heights

In a major milestone, Pakistan’s pharmaceutical sector has achieved global recognition for its innovation, regulatory reforms, and rising export performance. The industry’s growing global presence signals its evolution from domestic supplier to an emerging player in international health markets.

Pakistan hosts over 800 pharmaceutical formulation units, including subsidiaries of multinational companies, and supplies approximately 90% of domestic drug demand. Despite relying heavily on imported raw materials, the sector has significantly improved its compliance with manufacturing standards and taken steps toward global certification.

Pakistan’s pharma exports have seen remarkable growth in 2025, reaching USD 457 million, reflecting a 34% year-on-year increase, the highest in the last two decades. This performance is driven by innovation, trust from international markets, and favorable policy changes, including the deregulation of non-essential medicine pricing.

Leading Pakistani companies have received national recognition and export awards, highlighting their contributions to Pakistan’s growing pharmaceutical reputation.

Reform measures introduced by the Drug Regulatory Authority of Pakistan (DRAP) have been instrumental in driving this progress. These include stronger quality enforcement mechanisms, improved market access processes, and the introduction of digital tracking tools to improve transparency and efficiency.

Despite previous challenges, such as limited domestic production of Active Pharmaceutical Ingredients (APIs) and a dependence on imported raw materials, Pakistan is rapidly transforming. Currently, only a small percentage of APIs are manufactured locally, but initiatives are underway to scale production and reduce import dependency.

The government and industry stakeholders are investing in digital tools, trade expos, and policy reforms to strengthen Pakistan’s pharmaceutical exports. The focus is on innovation, competitive product development, and enhancing credibility through international partnerships.

Summary

Pakistan’s pharmaceutical sector is now gaining international credibility. With focused policy reforms, technological advancements, and a strong export orientation, the industry is positioning itself as a key contributor to global healthcare.